The effect of mifepristone on the expression of secretory leukocyte protease inhibitor (SLPI) in the endometrium of women using depot medroxyprogesterone acetate (DMPA) was investigated in this randomized, placebo-controlled trial. The study showed that the administration of DMPA led to a substantial inhibition of endometrial SLPI protein and mRNA, and that the addition of mifepristone to DMPA-exposed endometrium partially restored the expression of glandular SLPI.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.fertnstert.2007.01.046 | DOI Listing |
Publication Analysis
Top Keywords
mifepristone expression
8
secretory leukocyte
8
leukocyte protease
8
protease inhibitor
8
medroxyprogesterone acetate
8
expression endometrial
4
endometrial secretory
4
inhibitor medroxyprogesterone
4
acetate users
4
users mifepristone
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!